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Neurobiology of Disease
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The glymphatic system is a brainwide CSF transport system that uses the perivascular space for fast inflow of CSF. Arterial pulsations are
a major driver of glymphatic CSF inflow, and hypertension that causes vascular pathologies, such as arterial stiffening and perivascular
alterations, may impede the inflow. We used dynamic contrast-enhanced MRI to assess the effect of hypertension on glymphatic trans-
port kinetics in male young and adult spontaneously hypertensive (SHR) rats compared with age-matched normotensive Wistar-Kyoto
rats (WKY).We anesthetized the rats with dexmedetomidine/isoflurane and infused paramagnetic contrast (Gd-DOTA) into the cisterna
magna during dynamic contrast-enhanced MRI to quantify glymphatic transport kinetics. Structural MRI analysis showed that cere-
broventricular volumes are larger and brain volumes significantly smaller in SHR compared with WKY rats, regardless of age. We
observed ventricular reflux of Gd-DOTA in SHR rats only, indicating abnormal CSF flow dynamics secondary to innate hydrocephalus.
One-tissue compartment analysis revealed impeded glymphatic transport of Gd-DOTA in SHR compared with WKY rats in both age
groups, implying that glymphatic transport, including solute clearance from brain parenchyma, is impaired during evolving hyperten-
sion in young SHR, an effect that worsens in states of chronic hypertension. The study demonstrates the suppression of glymphatic
clearance in SHR rats and thus offers new insight into the coexistence of hypertension and concomitant vascular pathologies in Alzhei-
mer’s disease. The study further highlights the importance of considering the distribution of tracers in the CSF compartment in the
analysis of the glymphatic system.
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Introduction
While Alzheimer’s disease (AD) is the most common cause of
dementia, at least 15 million people worldwide currently suffer
from dementia arising wholly or in part from small vessel disease
(SVD) of the brain. Vascular pathologies, including hyperten-
sion, are risk factors for AD (Hachinski, 2015). SVD is common
in patients with chronic hypertension, and can progress silently
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Significance Statement
The glymphatic system contributes to the removal of amyloid from the brain and is disrupted in Alzheimer’s disease and aging.
Using a rat model of hypertension, we measured gross CSF flow and tracked glymphatic influx and efflux rates with dynamic
contrast-enhanced MRI, showing that glymphatic transport is compromised in both early and advanced stages of hypertension.
The study provides a new perspective on the importance for brainmetabolite and fluid homeostasis ofmaintaining healthy blood
vessels, an increasingly pertinent issue in an aging population that in part may explain the link between vascular pathology and
Alzheimer’s disease.
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for years before becoming clinically evident as cognitive dysfunc-
tion or dementia (Wardlaw et al., 2013). Themost common kind
of SVD is linked to arteriolosclerosis (i.e., to stiffening and
reduced elasticity of small arteries and arterioles), andmost com-
monly associated with aging, smoking, diabetes, and hyperten-
sion (Pantoni, 2010). In chronic hypertension, the increased
strain on arteries remodels the arterial wall (i.e., smooth muscle
hypertrophy, reduction of the lumen-media ratio, increase of
collagen content, and fatigue and fracture of elastin lamellae)
(Iadecola and Davisson, 2008; O’Rourke et al., 2010; Mitchell,
2014).
The glymphatic system is a brainwide fluid transport system
that uses the periarterial space for fast convective inflow of CSF,
driven by arterial pulsation (Iliff et al., 2012, 2013b; Mestre et al.,
2018a). Fluid exchange between CSF and interstitial fluid (ISF) is
facilitated by aquaporin-4 (AQP4) water channels, expressed at
high density on astrocytic endfeetmembranes that form the outer
wall of the perivascular space (PVS) (Iliff et al., 2012;Mestre et al.,
2018a,b). ISF and waste solutes drain along the perivenous space
of deep central veins and venous sinuses before exiting the brain
parenchyma via authentic lymphatic vessels located at the level of
the dura covering the brain and cranial nerves (Aspelund et al.,
2015; Louveau et al., 2015), which ultimately connects with cer-
vical lymphatic vessels (Holland et al., 2015;Mathieu et al., 2017).
Recently, acute hypertension induced by angiotensin II infusion
was shown to alter vessel wall pulsations, increasing backflow and
thereby reducing net flow of CSF in the PVS (Mestre et al.,
2018a).
Given the pulsation of arteries that drives the CSF-ISF ex-
change (Iliff et al., 2013b; Mestre et al., 2018a), we hypothesized
that effects of chronic hypertension, including stiffening and re-
duced elasticity of the vessel wall (Iadecola and Davisson, 2008),
may reduce the effectiveness of the arterial pulsation as a driver of
CSF-ISF and thus impair glymphatic transport (Fig. 1). To test
the hypothesis that CSF-ISF exchange is reduced with prolonged
hypertension, we used quantitative dynamic contrast-enhanced
MRI (DCE-MRI) (Lee et al., 2018) in combination with infusion
of Gd-DOTA, into the cisterna magna (CM) to measure glym-
phatic transport in spontaneously hypertensive rats (SHR), an
establishedmodel of the effect of hypertension onmicrovessels in
brain (Kaiser et al., 2014), and normotensive control (Wistar-
Kyoto) rats. Two age groups were included: one representing the
early emergence of hypertension (7–9 weeks) and the other the
established phase of chronic hypertension (19–21 weeks). We
quantified the rate of whole-brain glymphatic CSF-ISF exchange
by applying a single tissue-compartmentmodel to CSF and brain
Gd-DOTA time concentration curves (TCCs). To validate that
the whole-brain compartmental analysis was not biased by avail-
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Figure 1. a, Overview of tracer transport in subarachnoid CSF and PVSs. b, In the healthy brain, arterial pulse waves propagate the perivascular CSF via the subarachnoid space (SAS), driving a
convective CSF influx into the brain, where it exchanges with the ISF to drive the glymphatic system, here shown in a simplified model. c, We hypothesized that hypertension-induced vascular
pathology, including stiffening and reduced elasticity of the vessel wall, diminishes the ability of the arterial pulsewaves to propagate the perivascular CSF, thus reducing influx of CSF into the brain
in hypertensive rats.d, Here, the complex intracranial space of CSF, PVSs, brain parenchyma, Virchow–Robin spaces, ISF, and vasculaturewas segmented into two simplified compartments: CSF and
brain based on MR images. In these two compartments, TCCs were measured as the average Gd-DOTA concentration over time. e, A one-tissue compartment was fitted to the TCCs of the two
compartments using the CSF TCC as the input function and the brain TCC as the tissue function. From this, we calculated the glymphatic influx rate K1 and efflux rate constant k2. f, In the case of
whole-brain analysis, partial volume effects and imperfect segmentation of the intracranial space can lead to inclusion of CSF in the brain compartment. This inclusion is modeled as the volume of
CSF (VCSF), analogous to the blood volume in classical kinetic analysis.
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ability of tracer to the glymphatic system due to differences in
gross CSF flow caused by hydrocephalus, a condition inherent in
SHR rats (Tajima et al., 1993; Martínez-Pen˜a y Valenzuela et al.,
2006), we also determined the local parenchymal influx rate from
the PVS of the middle cerebral artery (MCA) to the proximal
brain tissue.
The study identified differences in brain anatomy and CSF
flow dynamics of young SHR compared with WKY that were
exacerbated in the adult SHRs. Supporting the main hypothesis,
glymphatic influx was significantly lower in young and adult
SHR, and glymphatic efflux, or clearance, was reduced in adult
SHRcomparedwith normotensive controls. Based on these novel
data, we propose that untreated hypertension may impair glym-
phatic system function, thereby contributing to accelerated brain
aging in hypertensive patients.
Materials andMethods
Compartmental modeling of Gd-DOTA transfer from CSF
to brain
We tested the hypothesis that the glymphaticCSF-ISF exchange is limited
in hypertension. To this end, we compared hypertensive and normoten-
sive rats by quantitative DCE-MRI to derive serial 3D maps of the con-
centration of gadolinium during and after the infusion of gadoteric acid
(Gd-DOTA) into the CSF of the CM (see below). We then kinetically
modeled the rate of tracer solution influx into brain tissue from CSF and
the efflux from the brain of the tracer solution.
Tracer mixes with CSF after infusion into the CM, and the tracer
solution undergoes transport into the subarachnoid CSF along the PVS
surrounding major arteries, predominantly in the direction of arterial
blood flow (Fig. 1a), entering the Virchow–Robin spaces of the penetrat-
ing arterioles. From here, AQP4 channels in themembranes of astrocytic
vascular endfeet facilitate the passage of CSF tagged with the tracer into
ISF (Fig. 1b). As arterial pulsation is a driver of this CSF-ISF exchange
(Iliff et al., 2013b; Mestre et al., 2018a), and since arterial distensibility is
reduced in chronic hypertension (Baumbach and Heistad, 1988), we
hypothesize that the CSF-ISF exchange is reduced in an animal model of
essential hypertension, SHR.
Here, we modeled the tracer solution transport system by two com-
partments: (1) an input compartment consisting of CSF; and (2) a tissue
compartment consisting of brain tissue (Fig. 1d). According to this
model, the tracer solution is transported from the CSF compartment to
brain with the influx coefficient K1 quantified as a clearance with unit of
milliliters of tracer solution per cubed centimeter brain tissue perminute
(ml  cm3  min1) and subsequently leaves the brain tissue with the
efflux rate constant k2 (min
1) (Fig. 1e,f ). For the tissue compartment,
we applied the following simplemodel to calculateK1 and k2 (Phan et al.,
2017), as follows:
dMB(t)
dt
 K1CCSF(t) k2MB(t), (1)
with the parameters K1 and k2, where MB(t) is the average Gd-DOTA
mass per tissue volume (mol/cm3) at time t, and CCSF(t) is the average
CSF Gd-DOTA concentration (mol/ml) at time t. The estimates of K1
and k2 yielded the tissue volume of distribution of the tracer as follows:
VECS
K1
k2
, (2)
where VECS is an estimate of an apparent volume of tracer solvent in a
quantity of brain tissue, with the unit ofml/cm3 and amagnitude close to
the volume of the ISF, because Gd-DOTA as an extracellular tracer only
distributes in the ISF of the brain.
We then applied an extension of this model to the whole brain with an
additional compartment in the shape of the tracer input compartment of
the entire CSF, modeled with a third parameter of the CSF volume
(VCSF). The CSF volume also accounts for the volume of CSF included in
the tissue compartment by misclassification of CSF-representing voxels
as tissue voxels due to the automatic tissue-CSF segmentation (see be-
low) or to the partial volume effect from CSF in Virchow–Robin spaces
along penetrating arterioles. The third parameter is analogous to the
blood volume fraction in conventional tracer kinetic analysis of brain
tissuewith vascular space. The observed tracer concentration in the tissue
compartment (MB(t)) is therefore a combination of the CSF and brain
tissue tracer concentrations (Fig. 1f ), that is:
MB
 t  1  VCSF)  MB(t VCSF  CCSF(t). (3)
Isolating MB(t) in Equation 3 and substituting it and its first derivative
with respect to t in Equation 1, the two-compartment model of whole-
brain analysis extends to the following:
dMB
(t)
dt
 K1  1 VCSF)  CCSF(t k2  MB
 (t VCSF  CCSF(t))
 VCSF 
dCcdf(t)
dt
, (4)
with the three parameters K1, k2, and VCSF.
The kinetic model measures the transport of tracer solution, not CSF
itself. As in other studies of the glymphatic system using tracers, the
model assumes that Gd-DOTA flow reflects CSF-ISF flow and exchange,
and that this reflection is invariant in the disease studied here. Equation
4 is a one-compartment first-order rate equation that models transport
process from CSF to the brain tissue compartment and does as such not
allow discrimination between convection and diffusion.
To avoid confusion between the terminologies of classical kinetic anal-
ysis and glymphatic analysis, in the latter of which the term “clearance” is
used to denote removal of fluidswith dissolvedmacromolecules from the
brain, we refer to K1 as the “influx rate” and k2 as the “efflux rate
constant.”
Animals
Male normotensive Wistar Kyoto rats (WKY; https://www.criver.com/
products-services/find-model/wistar-kyoto-wky-rat) and SHR rats
(https://www.criver.com/products-services/find-model/spontaneously-
hypertensive-shr-rat) were obtained from Charles River. The hyperten-
sive strain was developed and first described by Okamoto and Aoki
(1963) and remains the most commonly used animal model for cardio-
vascular disease due to its close resemblance to progressive hypertension
in humans (Doggrell and Brown, 1998). Rats are prehypertensive until
6–8 weeks of age, whereupon their systolic blood pressure increases
rapidly, finally attaining 200–220 mmHg at14 weeks of age (Adams et
al., 1989). The rats were housed in individually ventilated cages with ad
libitum access to water and food, and a 12/12 h light cycle from 6:00 A.M.
to 6:00 P.M., with 30min of twilight at each transition. All treatments and
imaging were performed according to protocols approved by the Danish
Animal Experiments Inspectorate. Separate groups of rats were scanned
at two age ranges: young (7–9 weeks old; yWKY, n 11; and ySHR, n
8) and adult (19–21 weeks; aWKY, n 8; and aSHR, n 9). The young
and adult SHR groups represent the emergent, early hypertension, and
chronic phases of hypertension, respectively.
MRI
All MRI investigations were conducted on a 9.4 T magnet (Bruker Bio-
Spec 9.4/30 USR) interfaced to a Bruker Advance III console and con-
trolled by Paravision 5.1 software (Bruker BioSpin) at the Faculty of
Health and Medical Sciences, University of Copenhagen. Imaging was
performed with an 86 mm (ID) volume resonator and a 4-channel sur-
face quadrature array receiver coil.
Experimental design
Rat imaging. Surgical anesthesia was induced with 3% isoflurane in oxy-
gen, followed by a single intraperitoneal injection of a mixture contain-
ing ketamine (100 mg/kg), dexmedetomidine (DEXM; 0.25 mg/kg), and
glycopyrrulate (0.2 mg/kg), and supplemented with 1.0%–1.5% isoflu-
rane for maintenance. Using a stereomicroscope (Leica Microsystems,
MZ6), the atlanto-occipital membrane was exposed. A drop of 20% alu-
minum chloride (Sigma-Aldrich) inwater was placed on the incision and
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the exposed skull to stop bleeding and improve
the subsequent curing of cyanoacrylate glue
following catheter insertion. The intracisternal
catheter was prepared by inserting a segment of
PE10 tubing (2.5 cm long, 0.28 mm ID 0.61
mm OD, Braintree Scientific) inside a pulled
glass capillary and gluing it in place (1 cm long,
0.68 mm ID  1 mm OD aluminosilicate mi-
cropipette; Sutter Instruments), with the tip of
the glass needle having an ID of150m. The
catheter was inserted 2–3 mm deep in the CM
and glued in place using cyanoacrylate glue. To
improve delivery of the tracer to the brain (Lee
et al., 2015), the animals were placed in a su-
pine position within the bore of the magnet,
and the CM cannula connected to a 100 l
Hamilton syringe mounted in a microinfusion
pump (Legato 130, KD Scientific) for the deliv-
ery of contrast agent (20 l, 13.5 mM Gd-
DOTA at 1.5 l/min to a total of 0.27 mol
Gd-DOTA; Guerbet).
DuringMR imaging, anesthesia was maintained with the highly selec-
tive 2-adrenergic receptor agonist DEXM with negligible respiratory
and cardiovascular side effects (0.015–0.020 mg/kg/h), delivered via a
subcutaneous catheter placed in the flank, and 0.6%–1% isoflurane, de-
livered via a face mask. The use of isoflurane alone for maintaining an-
esthesia is known to be problematic in studies of SHR and WKY rats
because of its cerebrovascular and systemic hemodynamic effects; isoflu-
rane reduces blood pressure in both strains and directly dilates cerebral
vasculature (Bencze et al., 2013), while also eliminating the strain differ-
ence in blood pressure in adult rats (Leoni et al., 2011). By using DEXM
in conjunction with a relatively low concentration of isoflurane, we at-
tempted to minimize potential experimental confounds arising from
anesthesia with pure isoflurane. Furthermore, a DEXM/0.8% isoflurane
combination, in contrast to 2% isoflurane, was recently shown to en-
hance glymphatic transport function and produce 9–15 Hz spindle os-
cillations compared with the high concentration isoflurane, thus
mirroring a natural sleep state (Benveniste et al., 2017). Physiological
parameters, including respiratory rate, oxygen saturation, heart rate, and
rectal body temperature, were continuously monitored using an MRI-
compatible monitoring system (SA Instruments). Body temperature was
kept within the range of 36.5°C-37.5°C using a temperature-controlled
waterbed, and physiological parameters were maintained by ongoing
adjustments of waterbed temperature, DEXM infusion rate, and isoflu-
rane concentration guided by vital signs.
Imaging parameters. The DCE-MRI protocol was adapted from previ-
ous work (Lee et al., 2018) to produce a quantitative and dynamic mea-
surement of gadolinium concentration in the brain after injection of the
contrast agent into the CM (for an overview, see Fig. 2). First, we ac-
quired a map of the RF transmission inhomogeneity (B1	) using a
double-angle (Stollberger andWach, 1996) rapid acquisition with relax-
ation enhancement (RARE) sequence (TE: 22 ms, TR: 10 s, number of
averages [NA]: 1, RARE factor: 4, 50 slices, in-plane resolution: 0.24 
0.24 mm, slice thickness: 0.4 mm; slice gap: 0.2 mm; flip angles [FA]: 70°
and 140°), and a precontrast 3D T1mapwas acquired using a variable FA
spoiled gradient method (VFA-SPGR) (TE: 4 ms, TR: 15 ms, NA: 1;
matrix: 128  128  128, voxel size: 0.24  0.24  0.26 mm [0.015
mm3], FA: 2, 5, 10, 15, 20, and 30°, scan time per FA: 4:05 min). Then, a
series of SPGR images (FA: 15°, otherwise same parameters as VFA-
SPGR) was acquired, consisting of three baseline scans followed by 40
contrast-enhanced scans; each acquisition lasted 4 min and 5 s to a total
scanning time of 160 min. A reference phantom filled with 0.1 mM
Gd-DOTA was placed in the FOV to allow intensity normalization be-
tween each scan as well as allowing receiver gain adjustment. Reference
TX power and receiver gain were kept the same during the scanning
session after calculation during the first RARE experiment.
For visualization purposes, we scanned additional 9 young animals (3
SHR and 6 WKY) with high-resolution, long-echo time T2-weighted
TURBORARE sequence (TE: 36 ms, TR: 16 s, NA: 3, RARE factor: 8, 128
slices, slice thickness: 0.312 mm; slice overlap: 0.156 mm, matrix: 384
384, in-plane resolution: 0.09 0.09 mm) 1 week before DCE-MRI. For
this procedure, anesthesia was induced with 3% isoflurane and main-
tained with 1.5% isoflurane. The long echo time produced a high con-
trast between water and brain tissue, allowing CSF and large PVSs to be
delineated from brain.
Blood pressuremeasurements. To validate that hypertension in the SHR
was not affected by the anesthesia, we measured blood pressure in 5
young WKY, 5 young SHR, 4 adult WKY, and 3 adult SHR under the
anesthetic regimen of of 3% isoflurane, 100 mg/kg ketamine, 0.25 mg/kg
DEMX (induction), and 0.015–0.020 mg/kg/h DEXM, 0.6%–1% isoflu-
rane (long-term anesthesia). Blood pressure wasmeasured as themedian
blood pressure 15–45 min after switch to long-term anesthesia. A 26
weeks of age, SHRwas included in the adult SHR group. Blood pressures
in all rats weremeasured through the femoral artery as described byGhali
(2017).
Spatial normalization and segmentation
The MRI series were corrected for motion by a rigid body registration
procedure and resampled into the coordinates for individual mean base-
line images. For the purpose of spatial image registration, the image bias
field created by the receiver coil was removed using a combination of
in-house software and Advanced Normalization Tools (ANTs N4 bias
correction) (Tustison et al., 2010), and baseline images were then skull-
stripped using 3D-PCNN (Chou et al., 2011) followed by a manual cor-
rection. Bias field-corrected, skull-stripped baseline images were then
used to create a population-based template consisting of the minimum
deformation spatial average, as previously described (Avants et al., 2011).
The images were rigidly registered to a randomly selected individual
image from the series and averaged to create an intermediate template.
This process was repeated using the intermediate template resulting from
the previous iteration, using first affine and then nonlinear registration
steps until the difference between iterations was negligible. Finally, all
mean baseline SPGR images were nonlinearly registered to the
population-based template and the calculated transformation applied to
the SPGR time series, allowing comparisons in a common space, “tem-
plate space.” To allow segmentation of individual time series, the Wax-
holm Space atlas of the Sprague Dawley rat brain (Papp et al., 2014) was
nonlinearly registered to template space and subsequently transformed
to the space of the SPGR time series. All registration procedures were
performed using the ANT software package version 2.1.0 (RRID:
SCR_004757). The skull-stripped images were segmented into CSF and
brain compartments using ANTs Atropos, with the bias-field corrected
baseline images and calculated T1 maps serving as inputs.
Data preparation
Signal enhancement in the post-contrast frames due to the infusion of
Gd-DOTA was calculated from the motion-corrected series of SPGR
images as maps of percent signal increase from baseline (enhancement
ratio [ER]) and concatenated into a 4D time series for each animal.
Double angle
B1+ mapping
10 min
VFA-SPGR 
T1-mapping
25 min
Precontrast SPGR
“Baseline”, 3 frames
12 min
Postcontrast SPGR
40 frames
160 min
Gd-DOTA infusion
20 µL over 13 m 20 s
MRI
Figure2. Overviewof thequantitative glymphaticMRI protocol. After surgical implantationof an intracisternal cannula, the rat
was placed in the supine position inside the MRI scanner and kept under anesthesia with a mixture of dexmedetomidine and
isoflurane. First, the B1	mapwas acquired using a double-angle experiment; then the precontrast T1mapwasmeasuredwith a
VFA-SPGR sequence, and 3 precontrast SPGR images were acquired. Then, during sequential acquisition of SPGR images, 20l of
13.5 mM gadoteric acid (Gd-DOTA) was infused through the cannula over 13 min 20 s, and SPGR imaging continued for a total of
160 min.
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Subsequently, the ER time series were transformed into units of Gd-
DOTA concentration ([Gd]) as described by Lee et al. (2018). Each voxel
in the resulting [Gd] map has a value corresponding to Gd-DOTA “con-
centration” (i.e., mass of Gd-DOTA per volume), but since said volume
does not correspond to the aqueous solution of the tracer, we report the
[Gd] maps in units of mol/cm3 to avoid confusion.
CSF flow patterns and ventricular morphometry
To characterize gross CSF flow differences between the groups, we cal-
culated an average [Gd] map time series in the template space, by aver-
aging the [Gd] maps for each group for each MRI time point. This
resulted in a mean [Gd] time series for each of the four groups (yWKY,
ySHR, aWKY, and aSHR). As reflux of CSF through the cerebral aque-
duct back into the ventricular system is a well-described phenomenon in
normal pressure hydrocephalus (Kim et al., 1999; Vanneste, 2000; Qvar-
lander et al., 2017), we quantified ventricular reflux by calculating the
total mass of Gd-DOTA contained in the lateral ventricles (LVs) 40 min
after CM injection of Gd-DOTA. The LVs and CMwere manually delin-
eated based on the previously calculated CSF segmentation using ITK-
SNAP software version 3.6, and total ventricular Gd mass (in nmol) was
then calculated as the sum of [Gd] in all ventricular voxels multiplied by
the volume per voxel, 0.015 mm3.
Quantification of whole-brain glymphatic influx and efflux
Hydrocephalus with CSF space enlargement as well as reduced brain
volume are well-characterized innate features of SHR rats (Tajima et al.,
1993; Martínez-Pen˜a y Valenzuela et al., 2006). The anatomical CSF
features of SHR rats change the overall CSF flow patterns and must be
accommodated when applying the methods normally used to measure
glymphatic influx and clearance inDCE-MRI (Lee et al., 2015; Jiang et al.,
2017; Ringstad et al., 2017).
To evaluate global glymphatic function in the SHR, we applied kinetic
modeling to CSF and brain TCCs as described above. From the individ-
ual [Gd] time series, we computed TCCs as the average Gd-DOTA con-
centration over time in CSF and brain, respectively, in the native space
images of individual rats using the segmentations of CSF and brain pre-
viously calculated. Using a gradient-expansion algorithm as imple-
mented in iFit software version 0.82 (http://www.liver.dk/ifit.html), a
one-tissue compartment model was fitted to the data for estimating the
influx rate fromCSF to brain (K1; ml  cm
3  min1) and the efflux rate
constant from brain (k2; min
1). To account for CSF included in the
brain compartment, the CSF volume fraction (VCSF; %) was included in
the model fit (Eqs. 3, 4).
Quantification of local glymphatic influx
Hydrocephalus and CSF reflux inevitably impact total tracer mass distri-
bution before it enters the glymphatic pathway. Since the impact of CSF
space enlargement on the availability of tracers to the glymphatic system
in the whole-brain kinetic analysis is unknown, we further validated the
results derived from the global glymphatic analysis in compartments not
affected by the innate hydrocephalus of SHR. We modeled the local
transport ofGd-DOTA from the PVS of theMCA into the cerebral cortex
(CTX) immediately medial to theMCA. Specifically, wemeasured TCCs
in twoROIs drawnmanually in the native space images of individual rats:
in each transverse image slice between the circle ofWillis (CoW) and the
rostral rhinal vein, the PVS was defined as a 3 3 voxel square centered
in the MCA but excluding nonbrain voxels. The CTX was defined as a
disc of six voxels diameter located directly medial-posterior to PVS. Due
to high noise levels in the [Gd] images maps along the brain-skull inter-
face, we instead used ER maps for this calculation.
We then fitted a one-tissue compartment model to the PVS and CTX
TCCs and calculated the magnitude of K1 (ml  cm
3  min1) and k2
(min1) using iFit software version 0.82. K1 for each animal was mea-
sured as the average of K1 measured in the right and left hemispheres, as
for k2. Care was taken when delineating the CTX compartment not to
include CSF in the drawn ROIs wherefore the CSF-volume parameter as
the MCA ROIs was not included in this analysis (Eq. 1). Since the CTX
compartment is contiguous with the surrounding brain tissue, the tracer
passes through the compartment without a well-defined destination.
Thus, the efflux rate constant from the CTX compartment, k2, is not a
meaningfulmeasure of glymphatic efflux in the context of the local glym-
phatic analysis.
Gd-DOTA transport in white matter
We additionally evaluated tracer kinetics in the corpus callosum in three
young SHR and 6 young WKY rats. We could only delineate the corpus
callosum in those animals for which we had acquired additional T2-
weighted TURBORARE images, which provided excellent anatomical
contrast. Corpus callosum was delineated manually using ITK-SNAP
software version 3.6, and TCCs were calculated from the dynamic [Gd]
images.
Immunohistochemistry
The effects of astrogliosis and AQP4 expression in the astrocytes were
also evaluated in the present study to assess their putative correlation to
the glymphatic CSF-to-brain clearance. A subset of the young (yWKY,
n 3; ySHR,n 3) and adult rats (aWKY,n 3; aSHR,n 3)were after
the DCE-MRI experiment anesthetized by intraperitoneal injection of a
mixture of ketamine and xylazine (100 mg kg1/10 mg kg1) and per-
fused transcardially with 100 ml 0.01 M PBS, pH 7.4 (Sigma-Aldrich)
containing heparin (10,000 units/L; SAI Infusion Technologies). Vascu-
lature was labeled by perfusing 10 ml of a solution containing 100g/ml
wheat lectin (Triticum vulgaris) conjugated to FITC (Sigma-Aldrich),
and followed by 140 ml 4% PFA solution (Sigma-Aldrich), both diluted
in 0.01 M PBS, pH 7.4. Brains were dissected, postfixed overnight in 4%
PFAat 4°C, and cryopreserved by incubation in sucrose solutions of 10%,
20%, and 30%, diluted in 0.01 M PBS, pH 7.4. Rat brains were embedded
in optimal cutting temperature compound (Sigma-Aldrich) and frozen
in isopentane on dry ice; 30 m sections were obtained using a cryostat
(Leica Microsystems, CM186). After PBS washes, histological sections
were blocked for 1 h at room temperature in a solution containing 0.3%
Triton X-100 (Sigma-Aldrich) and 5% normal donkey or goat serum
(Invitrogen; Thermo Fisher Scientific) diluted in 0.01 M PBS, pH 7.4,
followed by overnight incubation at 4°C with the following primary an-
tibodies diluted in blocking solution: polyclonal chicken anti-GFAP (1:
500, Thermo Fisher Scientific) and polyclonal rabbit anti-AQP4, C
terminus (1:500, Merck). Immunolabeling was revealed by incubation
with the appropriate secondary antibodies coupled to fluorophores (Al-
exaFluor, 1:500; Invitrogen; Thermo Fisher Scientific) for 2 h at room
temperature. DAPI (1 g/ml; Thermo Fisher Scientific) was used for
nuclear counterstaining, and slides were mounted with Prolong Gold
Antifade Reagent (Invitrogen; Thermo Fisher Scientific). Images of the
immunolabeled slides were acquired on a confocal microscope (Nikon
Eclipse Ti) with Plan Fluor 20/0.75 Mlmm or an epifluorescence
microscope (Nikon Ni-E) with Plan Apo  4/0.20 objective. Con-
focal imaging acquisition was manually corrected to equalize the
lectin signal across the optical sections. For the wavelengths corre-
sponding to the signal of GFAP and AQP4, laser power and digital
gain were kept the same for all acquired images, for both WKY and
SHR samples. Acquired images were adjusted for brightness and con-
trast using FIJI/ImageJ software.
Statistical analysis
Measurements are reported as mean
 SD. Unless noted, statistical tests
were performed as one-tailed (in cases with a hypothesized direction of
change, e.g., decreased influx rate in SHR) or two-tailedMann–Whitney
U tests. Analyses were conducted using Prism 7, MATLAB 9.3 (RRID:
SCR_001622), and image scripting was performed in Python version
2.7.10 (RRID:SCR_008394). 3D volume rendering was created using
MRIcro version 1.8.9 (http://www.mccauslandcenter.sc.edu/crnl/mricro)
software.
Results
Image series from 6 rats were excluded from the analysis due
either to failed infusion of Gd-DOTA (3 rats) or to premature
termination of the experiment for technical reasons (3 rats). Ad-
ditionally, quantification of the Gd-DOTA concentration ([Gd])
failed in three experiments due to suboptimal coil placement;
these experiments were excluded from analyses requiring the
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[Gd] time series but were included in other analyses. All rats
included in analyses were physiologically stable for the duration
of the scan. Body weights as well as average heart rate and respi-
ratory rate during the scanning period are summarized in Table
1, alongwith statistical comparisons within age groups (yWKY vs
ySHR, and aWKY vs aSHR). Mean respiratory rates were signif-
icantly lower in the aSHR group compared with the normoten-
sive age-matched controls.
Blood pressure under anesthetic regimen
Blood pressuresmeasured in 5 youngWKY, 5 young SHR, 4 adult
WKY, and 3 adult SHR under the anesthetic regimen forMRI are
reported in Table 2. Blood pressure was significantly higher in
SHR than WKY in both age groups despite anesthesia.
Morphological brain changes in SHR rats
Hydrocephalus and reduced brain volume were evident in our
cohorts of both young and adult SHRs compared with WKYs
(Fig. 3b–d; summarized in Table 3). The intracranial volumes
and brains of the SHR rats were significantly smaller than their
normotensive controls (Fig. 3b), with 11% lower brain volume in
the young group and 12% lower in the adult group. As expected,
ventricular volumes were higher in SHRs compared with WKYs
(Fig. 3c,d), with fivefold higher LV volumes in the young SHRs
and sixfold higher LV volumes in the adults, as well as a 21%
higher CM volume in the young group and 49% higher CM
volume in the adult group (Table 3). Surprisingly, total CSF vol-
ume (including subarachnoid space CSF and ventricular system)
did not differ significantly between the young SHR and WKY,
and nonventricular CSF volume (excluding lateral, third, and
fourth ventricles) was indeed 7% lower in the young SHR (Table
3). Conversely, total CSF volume was 8% greater in adult SHR
than their age-matched controls, although no difference was
found in nonventricular CSF volume (Table 3). Calculated as a
percentage of intracranial volume, total CSF volume was higher
in SHR in both age groups, whereas the relative nonventricular
CSF volume was greater in the adult group of SHR but did not
differ in the young group (Table 3). Small CSF spaces (e.g., the
subarachnoid space) are smaller than the resolution of the SPGR,
and thus CSF volumes are likely to be overestimated. Since the
segmentation was automatic, this overestimation was not likely
to be biased in either strain.
To further elucidate the differences in nonventricular CSF
volumes, we measured the volumes of the CSF-filled subarach-
noid space surroundingCoWand the basal part of the brainstem,
as these are major passageways for tracer from CM to the brain.
As we worried that the spatial resolution of the SPGR images was
too low to precisely measure these volumes, we manually delin-
eated them using the higher-resolution, higher CSF-contrast
TURBORARE images, which were only acquired for 3 young
SHR and 6 young WKY. We found no significant difference in
subarachnoid CSF volume surrounding CoW (yWKY, 6.17 

0.25mm3; ySHR, 5.71
 0.31mm3; p 0.095, two-tailedMann–
WhitneyU test), but subarachnoid CSF volume was significantly
lower in basal brain stem (yWKY, 0.76 
 0.03 mm3; ySHR,
0.57
 0.07 mm3; p 0.024, two-tailed Mann–WhitneyU test).
Changes in CSF flow patterns in SHR rats
We qualitatively evaluated the transport of Gd-DOTA from CM
into the cerebral ventricles by volume rendering the group mean
[Gd] time series (Fig. 3e,f). In the ySHR group, Gd-DOTA
reached the fourth ventricle (4V), third ventricle (3V), and LVs at
12, 24, and 32 min, respectively, after injection. In the average
yWKY group, the contrast agent did not reflux into the ventricles
but was instead transported dorsally from the CM over the cere-
bellar vermis to the pineal recess, making its first appearance at 8
min after injection in the average yWKY group but not in the
average ySHR group. Similar flow characteristics were observed
in the adult groups: contrast agent was apparent in the 4V at 8
min after injection, in 3V at 16 min and in LV 24 min after
injection in the average aSHR, with no contrast agent being ob-
served in the ventricular system of the aWKY group.
To quantify ventricular reflux, we measured the total mass of
contrast agent that accumulated in the LV at 40 min after injec-
tion (Fig. 3g). We observed 10-fold more Gd-DOTA in the LV of
ySHR compared with controls (yWKY, 0.11
 0.07 nmol; ySHR,
1.42
 1.62 nmol; p 0.006), and 30-foldmoreGd-DOTA in the
adult SHR rats (aWKY, 0.10 
 0.13 nmol; aSHR, 3.48 
 3.96
nmol; p 0.0025). Regardless of age, transfer of contrast agent to
LV was considerably more variable in SHR than in WKY rats.
Effects of hypertension on the global glymphatic transport
To calculate kinetic glymphatic parameters, we first computed
TCCs from CSF and brain, respectively (Fig. 4), using the dy-
namic parametric [Gd] maps, available in 9 yWKY, 6 ySHR, 5
aWKY, and 7 aSHR; average TCCs for both CSF and brain are
shown in Figure 4a–d.
Peak average [Gd] in brain tissue did not differ significantly in
the young group (yWKY, 0.042 
 0.005 mmol/cm3; ySHR,
0.037 
 0.003 mmol/cm3; p  0.11), but was 20% lower in the
adult SHR compared with WKY (aWKY, 0.039 
 0.007 mmol/
cm3; aSHR, 0.031 
 0.004 mmol/cm3; p  0.018; two-tailed
Mann–WhitneyU test). Peak total mass of Gd in brain tissue was
22% lower in young SHR (yWKY, 79.4
 9.7 nmol, 29.4
 3.6%
of the injected dose [%ID]; ySHR, 61.8 
 4.9 nmol, 22.9 

1.8%ID; p  0.0004) and 28% lower in adult SHR (aWKY,
80.3
 14.1 nmol, 29.7
 5.2%ID; aSHR, 57.6
 5.2 nmol, 21.3

1.9%ID; p 0.01; two-tailed Mann–Whitney U test). No signifi-
cant differences were found in the time-to-peak (TTP) Gd con-
centration (yWKY, 61.9
 8.4 min; ySHR, 81.0
 31.7 min; p
0.28; aWKY, 59.2
 10.0 min; aSHR, 65.0
 20.4 min; p 0.90;
two-tailed Mann–Whitney U test).
We then quantified global glymphatic influx and efflux rates
using a one-tissue compartment model, including aVCSF param-
eter (Fig. 4e,f). For full results, including root mean square error
Table 1. Summary of weights and average heart and respiration rates during scan
(mean SD)
Age
(wk) Strain N (excluded) Weight (g)
Heart
rate (min)
Respiratory
rate (min)
7–9 WKY 9 (2) 245
 16 251
 23 61
 6
SHR 7 (1) 216
 23 275
 30 59
 5
19–21 WKY 6 (2) 366
 9 238
 26 68
 5
SHR 8 (1) 338
 31 252
 12 56
 7**a
**p 0.01 (two-tailed t test with unequal variance: yWKY vs ySHR and aWKY vs aSHR, followed by Bonferroni
correction for multiple comparisons); ap 0.0067, df 11, t 3.81.
Table 2. Summary of results from the blood pressuremeasurements under the MRI
anesthesia regimen
Age (wk) Strain N BP (mmHg)
7–9 WKY 5 78.8
 14.5
SHR 5 119.4
 10.6**a
19–21 WKY 4 72.1
 5.5
SHR 3 139.3
 13.6*b
*p 0.05; **p 0.01; one-tailed Mann–Whitney U tests (SHRWKY); ap 0.004; bp 0.029.
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Figure 3. a, Gross morphological and CSF flow changes in the SHR compared with WKY. Example segmentations of baseline SPGR images into brain tissue and CSF. Brain volumes were
significantly lower in both young and adult SHR than their normotensive controls (b), and the volumes of LVs (c) and CM (d) were significantly higher for the SHR comparedwithWKY. Gd-DOTAwas
infused into the CM starting at injection	 0min and continuing for 13min 20 s. e, Volume rendering of average Gd-DOTA concentration time series for each of the four groups revealed differences
in gross CSF flow. f, In both young and adult SHR, Gd-DOTA appeared in the 4V, 3V, and LVs within 32 min after the start of the infusion. Overview of brain and ventricular anatomy. Total mass of
Gd-DOTA in the LVs 40 min after the start of infusion was markedly higher in the SHR in both age groups (g). *p 0.05, **p 0.01. CB, Cerebellum; OB, olfactory bulb; SAS, subarachnoid space;
AQ, aqueduct.
Table 3. Summary of brain and ventricle sizes in SHR andWKY
Age (wk) Strain N Intracranial (cm 3) Brain (cm 3) CSF (cm 3)
Nonventricular
CSF (cm 3) LV (mm3) CM (mm3) CSF (%n)
Nonventricular
CSF (%n)
7–9 WKY 9 2.45
 0.06 1.89
 0.04 0.56
 0.03 0.55
 0.03 6.5
 1.7 17.7
 1.7 22.7
 0.8 22.3
 0.8
SHR 7 2.24
 0.06***a 1.69
 0.06***c 0.55
 0.04 0.51
 0.02*f 38.6
 16.5***g 21.4
 2.2**i 24.6
 1.5*k 22.7
 0.8
19–21 WKY 6 2.66
 0.03 2.07
 0.03 0.59
 0.02 0.58
 0.02 9.6
 7.4 16.9
 2.2 22.1
 0.7 21.7
 0.6
SHR 8 2.47
 0.07***b 1.83
 0.06***d 0.64
 0.03**e 0.57
 0.01 68.0
 17.4***h 25.2
 2.4***j 25.9
 1.0***l 22.9
 0.6**m
*p 0.05; **p 0.01; ***p 0.001; two-tailedMann–Whitney U tests; ap 0.00017; bp 0.00067; cp 0.00017; dp 0.00067; ep 0.008; fp 0.012; gp 0.00017; hp 0.00067; ip 0.002; jp 0.00067; kp 0.012; lp
0.00067; mp 0.0027; npercentage of intracranial volume.
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of the fitted model, see Table 4. The global glymphatic influx rate
(K1) was significantly lower in both young and adult SHR than in
corresponding WKY groups (Fig. 4g), with 29% lower K1 in
young SHR and 36% lower K1 in adult SHR. The global glym-
phatic efflux rate (k2) was also reduced in adult SHR by 26%, but
not significantly in young SHR (Fig. 4h). The analysis addition-
ally showed a lower volume of distribution (VECS), which is the
apparent extracellular space volume fraction in the brain, in the
young group by 25%, but not in the adult group. The estimates of
CSF volume in the brain tissue compartment calculated from the
one-tissue compartment model did not differ significantly be-
tween the SHR andWKY groups in either age group, althoughwe
observed a tendency toward lower VCSF in the adult groups. Av-
erage modeled TCCs are shown in Figure 4i, j with individual
residual errors.
Since CoW is a main passageway for tracer from CM to the
brain, we speculated that the decreased glymphatic influx rate
was caused by a decreased availability of tracer in the PVS sur-
rounding CoW. To test this, we measured the TTP and area un-
der the curve (AUC) for TACs from subarachnoid CSF
surrounding CoW. No differences were found in either TTP
(yWKY, 30.6
 8.7 min; ySHR, 30.6
 5.2 min; p 0.81; aWKY,
28.9
 4.7min; aSHR, 31.8
 8.4min; p 0.72) or AUC (yWKY,
48.3
 6.7; ySHR, 45.2
 8.8; p 0.6; aWKY, 49.2
 11.8; aSHR,
42.7
 3.3; p 0.34; two-tailed Mann–Whitney U test).
Effects of hypertension on perivascular CSF flow and local
glymphatic transport
To validate the findings of a lowered glymphatic influx rate in
whole brain of SHRs independently of changes in gross CSF flow
and morphology, we calculated the local tracer transport from
the PVS of the MCA to the CTX by fitting a one-tissue compart-
ment model to TCCs from the subarachnoid PVS (input com-
partment) surrounding the MCA, and adjacent CTX (tissue
compartment), thereby deriving the local glymphatic influx rate
K1 (Fig. 5). ER time series were available for 9 yWKY, 7 ySHR, 6
aWKY, and 8 aSHR animals. K1 for each animal was measured as
the average of K1 measured in the right and left hemispheres,
same as for k2. Figure 5a–d shows a representative volume ren-
dering of the perivascular flow measured in a yWKY rat overlaid
a high-resolution T2-weighted TURBORARE MRI to visualize
the PVS.Here, contrast agent traveled along the ventral surface of
the brain and reached the PVS surrounding theCoW, fromwhere
it followed a perivascular route along the MCA (Fig. 5b). The
ROIs for the two compartments are illustrated in Figure 5d, e
(which shows an example of the one-tissue compartment model
fit to the measured TCCs).
This analysis (for full results, including root mean square er-
ror of the fitted model, see Table 5) showed that the mean mag-
nitude of the local glymphatic influx rate (K1) was significantly
lower in adult hypertensive animals by 30% (Fig. 5g). No signif-
icant differencewas identified in the young group, although there
was a tendency toward lower average K1 (p 0.105). No signif-
icant differences of k2 were found between the groups (Fig. 5h).
Average modeled TCCs are shown in Figure 5i, j with individual
residual errors.
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Figure 4. Average TCCs of Gd-DOTA showed occasionally slightly higher CSF Gd-DOTA con-
centration in the CSF of young (a) and adult (b) hypertensive rats and their normotensive
controls. Average TCCs of Gd-DOTA in the brain compartment of young SHR and WKY (c) and
adult SHR and WKY (d). Average TCCs are shown as mean
 SD. e, Schematic overview of the
one-tissue compartmentmodel applied to brain and CSF TCCs to calculate the glymphatic influx
rate (K1) and efflux rate constant (k2). f, Example of the one-tissue compartment model fit.
4
The calculated K1 was significantly lower in the SHR than inWKY in both age groups (g), and k2
was lower in the adult, but not the young, SHR compared with their age-matched controls (h).
Averagemodeled time-activity curves and residuals from the young (i) and adult (j) agegroups.
*p 0.05, **p 0.01.
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Figure 5. a, A representative volume rendering of the CSF tracer Gd-DOTA through the perivascular/subarachnoid spaces on the brain surface of a 7-week-old normotensiveWistar Kyoto rat. b,
Zoomed view of the CSF tracer traveling up along the PVS surrounding theMCA. c, Anatomical and vascular reference for a,b. d, Illustration of the placement of the ROIs for the PVS surrounding the
MCA and the cortical compartment proximal to theMCA. e, We fitted a one-tissue compartment model to the PVS (input) and CTX (tissue) compartments, not including a VCSF parameter, since the
tissue compartmentwasmanually delineated to not include CSF. f, Example fit of the one-tissue compartmentmodel to the TCCs froma 7-week-oldWKY. The calculated local glymphatic influx rate
(K1) was significantly lower in the SHR than inWKY in the adult rats (g), restating the results from the global one-tissue compartment analysis, although no difference was found in k2 (h). Average
modeled time-activity curves and residuals from the young (i) and adult (j) age groups. *p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Table 4. Summary of results from the global glymphatic transport analysis
Age (wk) Strain N K1 (ml  cm
3  min1) k2 (min) VECS (%) VCSF (%) Fit RMSE (mmol/cm
3)
7–9 WKY 9 0.0069
 0.0017 0.0242
 0.006 29.5
 6.8 5.4
 2.1 0.0016
 0.0011
SHR 6 0.0049
 0.0014**a 0.0226
 0.007 22.0
 2.7*d 4.0
 3.1 0.0012
 0.0005
19–21 WKY 5 0.0058
 0.0008 0.0205
 0.002 28.5
 5.2 6.9
 2.2 0.0012
 0.0001
SHR 7 0.0037
 0.0011*b 0.0151
 0.004*c 24.8
 4.9 4.4
 1.7 0.0011
 0.0001
*p 0.05; **p 0.01; K1 , k2 ; one-tailed Mann–Whitney U tests (SHRWKY); VECS , VCSF: two-tailed Mann–Whitney U tests;
ap 0.0088; bp 0.015; cp 0.036; dp 0.0027.
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Tracer uptake in corpus callosum
Tracer uptake in corpus callosum was very low, with Gd-DOTA
concentrations peaking at0.005mol/cm3 in both young SHR
andWKY. TCCs in corpus callosum did not differ between the 3
young SHR and 5 young WKY rats in our analysis (data not
shown), and low SNR due to low uptake prevented further
analysis.
Gd-DOTA transport in hippocampus
It was recently demonstrated that fluorescent tracers passively
released from a needle in hippocampus spread at a higher rate in
SHR thanWKY with the conclusion that SHR displays enhanced
drainage (Bedussi et al., 2017). To test this, we measured TACs,
TTP, and AUC in the hippocampal areas. We found no signifi-
cant differences in AUC (yWKY, 3.84
 1.28; ySHR, 3.39
 0.76;
p  0.52; aWKY, 2.89 
 1.43; aSHR, 2.31 
 1.06; p  0.53;
two-tailed Mann–Whitney U test) or TTP (yWKY, 82.8 
 20.6
min; ySHR, 89.1
 20.8 min; p 0.54; aWKY, 94.3
 14.0 min;
aSHR, 111.1
 23.5 min; p 0.26; two-tailed Mann–WhitneyU
test), and the direction of all nonsignificantmean differences was
in the direction of decreased glymphatic flow in hippocampus.
GFAP and AQP4 distribution
To evaluate the effect of astrogliosis and AQP4 expression, histo-
logical sections from 3 young SHR, 3 young WKY, 3 adult SHR,
and 3 adultWKYwere immunolabeled for GFAP andAQP4 (Fig.
6). Representative micrographs of the GFAP staining (Fig. 6a–d)
show the distributions of astrocytes in the cortical parenchyma
around the area overlaid by the MCA. We quantified GFAP and
AQP4 distribution as the percentage area covered and used the
average of two micrographs per animal. Two-sample t tests were
applied to estimate differences, as the Mann–Whitney test is un-
derpowered for such small sample sizes. In young animals, a sig-
nificant difference was observed between WKY and SHR rats
(Fig. 6e; 95.47
 3.90 and 75.31
 2.35, respectively, p 0.0016,
t  7.66, df  4; two-tailed t test). Such difference was not ob-
served in adult rats (91.40
 1.59 and 90.54
 3.12; p 0.69, t
0.42, df 4; two-tailed t test). Differently from GFAP, no signif-
icant difference was observed in the immunoreactivity of AQP4
(representative micrographs are shown in Fig. 6f–i) between
WKYand SHR in young or adult animals (Fig. 6j; yWKY, 55.54

3.14; ySHR, 59.11
 0.73; p 0.13, t1.9, df 4; two-tailed
t test; aWKY, 87.58 
 5.70; aSHR, 89.74 
 1.52; p  0.56, t 
0.63, df 4; two-tailed t test).
Discussion
We used DCE-MRI to compare CSF flow characteristics and
CSF-ISF transport kinetics as measures of glymphatic transport
in young and adult SHR rats and age-matched normotensive
controls (WKY) after infusing Gd-DOTA into the CM. Notably,
the ventricular system anatomy and associated CSF transport
pattern differed dramatically between SHR andWKY rats due to
hydrocephalus in SHRs. Young and adult SHR rats displayed a 5-
to 6-fold larger LV volume compared with WKY rats, along with
enlargement of CM volume and10% loss of brain volume con-
sistent with prior reports (Ritter and Dinh, 1986; Martínez-Pen˜a
y Valenzuela et al., 2006). Despite this, CSF volume was lower in
young SHR and similar in adult SHR compared with WKY. We
also noted enlargement of brain ventricles with increasing age in
SHR rats, also consistent with prior reports (Ritter and Dinh,
1986). Finally, we observed CSF flow dynamics with ventricular
reflux in the hydrocephalic SHR rats, as has been observed in
humans with hydrocephalus (Ringstad et al., 2017, 2018), which
also demonstrated reflux of contrast agent into the LVs. Ventric-
ular reflux of CSF and increased CSF backflow through the aque-
duct are well-established clinical phenomena in hydrocephalus
(Vanneste, 2000; Qvarlander et al., 2017).
Glymphatic transport is impaired in SHR compared with
WKY rats
We developed a novel analysis method, in which we applied a
one-tissue compartment model to estimate the influx rate of Gd-
DOTA from CSF to the brain as well as the efflux rate from the
brain. Our kinetic analysis demonstrated decreases in both glym-
phatic influx and efflux. Reduced glymphatic influx has previ-
ously been associated with impaired glymphatic system function,
and thus a reduced ability of the brain to be cleared ofmacromol-
ecules and fluids (Iliff et al., 2012, 2013a; Kress et al., 2014; Plog et
al., 2015; Peng et al., 2016). The analyses showed lower glym-
phatic influx rates in SHR versusWKY rats, in both age groups, as
well as reduced efflux rates in the adult SHR. A second analysis of
local PVS-to-cortex transport showed a decreased glymphatic
influx in adult SHR, whereas the difference of influx in young
SHRdid not reach significance.We found no differences in tracer
dynamics in subarachnoid CSF surrounding CoW, implying that
a comparable amount of tracer is available in the subarachnoid
space at the basal brain. Thus, we conclude that the differences
observed in influx parameters most likely are not caused by
changes in gross flow patterns caused by ventriculomegaly in the
SHR, although the study cannot provide a direct causal link be-
tween hypertension-induced vascular pathologies and reduced
glymphatic influx.
Whereas previous studies have used amount of brain tracer
uptake and area coverage as markers of glymphatic influx (Iliff et
al., 2012, 2013a; Kress et al., 2014; Plog et al., 2015; Peng et al.,
2016), the present study shows that brain tracer concentrations
after CM tracer infusion depend on the efficacy of the glymphatic
system, the availability of tracer in CSF proximal to brain, and the
period between infusion and measurement of tracer concentra-
tion. Quantifying glymphatic influx exclusively using single-time
point histological sections disregards the availability and spatio-
temporal dynamics of tracer, and the current study thus high-
lights the importance of considering tracer distribution in CSF in
glymphatic system dynamics analysis.
Bedussi et al. (2017) recently showed an increased spread of
fluorescent tracer in hippocampus of aged SHR compared with
WKY when passively released from the needle in hippocampus,
concluding that SHR displays enhanced drainage. In apparent
contradiction, we found no difference in tracer uptake in hip-
pocampus with an insignificant tendency toward lower uptake in
SHR. The experiment by Bedussi et al. (2017) was conducted in
rats under 3% isoflurane anesthesia, a concentration at which
blood pressure (Bencze et al., 2013; Kato et al., 2016) and cardiac
output (Seyde et al., 1987) are significantly reduced and cerebral
blood flow increased in SHRversusWKY (Leoni et al., 2011). The
anesthetic regimen used may have produced differing alterations
Table 5. Summary of results from the local glymphatic transport analysis
Age (wk) Strain
Local K1
(ml  cm3  min1) Local k2 (min
1) Fit RMSE (%)
7–9 WKY 0.047
 0.015 0.081
 0.025 11.6
 4.62
SHR 0.036
 0.010 0.077
 0.016 11.7
 3.88
19–21 WKY 0.050
 0.019 0.078
 0.040 13.4
 5.77
SHR 0.035
 0.011*a 0.064
 0.017 9.22
 3.26
*p 0.05; one-tailed Mann–Whitney U tests (SHRWKY); ap 0.02.
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in interstitial fluid motion in the two strains due to the glym-
phatic system’s reliance on arterial wall pulsation, and thus the
results of the current study may not be directly comparable. In
addition, invasive procedures, such as inserting an injection pi-
pette, is linked to a sharp reduction in glymphatic CSF tracer
influx (Mestre et al., 2018b).
Hypertension-induced remodeling of the cerebral vasculature
The cerebral vasculature is distinct from the peripheral vascula-
ture because the majority of the cerebrovascular resistance is at
the level of large arteries (Faraci andHeistad, 1990). Large-caliber
vessels, for instance, the internal carotid artery and the MCAs,
absorbmost of the systolic pulsewave and aremore susceptible to
intraluminal pressure changes seen in hypertension (Hsu et al.,
2017). When arterial pressure rises, arteries must constrict to
maintain normal cerebral blood flow. Over time, this causes hy-
pertrophic and eutrophic remodeling of the vascular wall, result-
ing in increased wall stiffness and a reduction in the vessel lumen
(Iadecola andDavisson, 2008; Lindesay et al., 2016). Stiffening of
the arterial wall could alter vessel wall pulsatility, reducing the
efficiency of perivascular pumping, which is a key driver of CSF
transport (Rennels et al., 1985; Hadaczek et al., 2006; Iliff et al.,
2013b; Kiviniemi et al., 2016; Mestre et al., 2018a). Effective PVS
fluid transport requires coordinated arterial wall motion and
elasticity, which is significantly impaired in SHR rats due to vas-
cular remodeling (Gaballa et al., 1992; Lichtenstein et al., 1998).
Vascular remodeling and glymphatic activity in other models
of SVD
Diabetes also causes reduced vessel compliance and development
of SVD with arteriolosclerosis (Lehmann et al., 1992; Pantoni,
2010). Patients with Type I or II diabetes exhibit hypertrophic
remodeling, with increasedmedial cross-sectional area of the ves-
sels (Rumble et al., 1997; Creager et al., 2003). A recentDCE-MRI
study in a rat model of diabetes mellitus (Jiang et al., 2017) dem-
onstrated a reduction by approximately two-thirds of the glym-
phatic efflux rate in the diabetic rats compared with nondiabetic
control rats. The study also demonstrated higher accumulation
of tracer in the brain of the diabetic rats, which a second study
(Davoodi-Bojd et al., 2019) attributed to reduced clearing of
tracer in the diabetic group.
The main finding in the current study (i.e., decreased glym-
phatic influx rate) is comparable to previous findings in aging
normotensive mice (Kress et al., 2014) and in the APP/PS1 mu-
rine model of AD (Peng et al., 2016). The convergent effects of
hypertension, aging, diabetes, and ADwith respect to glymphatic
kinetics fit well with the general notion that hypertension accel-
erates aging of the brain vasculature and endothelial cells (Taddei
et al., 1997; Barton et al., 2016), and that hypertension, like AD, is
linked to cognitive impairment (Morris et al., 2001; Qiu et al.,
2005).
One of the most important roles of the glymphatic system is
removing interstitial soluble protein metabolites, such as A and
tau, culprits in AD and VaD (Iliff et al., 2012, 2014). The removal
of A from the CNS has previously been shown to be dependent
on the expression pattern of AQP4 channels in astrocytes, such
that mice with deletion of AQP4 exhibited a highly significant
reduction of glymphatic clearance of A (Iliff et al., 2012; Plog et
al., 2015). The role of AQP4 in convective ISF transport was
recently questioned by Smith et al. (2017) who failed to replicate
earlier studies. However, using four separately generated mouse
models of AQP4 disruption as well as one lacking perivascular
AQP4 expression, five independent laboratories have confirmed
the reliance of glymphatic transport onAQP4 expression (Mestre
et al., 2018b). In postmortem brains of patients suffering from
AD and CAA, total AQP4 expression was found to be increased
(Moftakhar et al., 2010; Zeppenfeld et al., 2017). These studies
highlight the importance of polarized expression of AQP4 on the
astrocytic endfeet lining the PVS, rather than on the astrocyte cell
body and perisynaptic processes (Kress et al., 2014; Xu et al.,
2015; Peng et al., 2016). The loss of polarized AQP4 expression is
associatedwith compromised local glymphatic activity (Iliff et al.,
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Figure6. a,b, Representative confocalmicrographs frombrain sections obtained fromyoungWKY and SHR, respectively, reveal the distributions of astrocytes in the cortical parenchyma around
theareaoverlaidby theMCA. c,d, Representativemicrographsof astrocytedistribution inbrain sections obtained fromadultWKYandSHR, respectively.e, Graphic representationof the fluorescence
intensity, expressed by percentage of covered area, of GFAP immunoreactivity. In young animals, a significant difference was observed betweenWKY and SHR. Such difference was not observed in
adult rats. f, g, Representative images of AQP4 distribution in the cortical parenchyma, also in the area overlaid by theMCA, of youngWKY and SHR. h, i, AQP4 distribution in the adult brain ofWKY
and SHR. j, Unlike GFAP, no significant differencewas observed in the immunoreactivity of AQP4 betweenWKY and SHR in young or adult animals. Scale bars, 50m. **p 0.01. Three animals in
each group; average of 2 micrographs per animal.
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2014; Kress et al., 2014). In SHR, earlier studies have shown that
GFAP immunoreactivity starts to increase at 2–3 months of
age, concurrently with increased AQP4 expression (Sabbatini et
al., 2000, 2002; Tomassoni et al., 2010). In the current study, we
see no such differences in GFAP and AQP4 between strains, with
the exception of decreased GFAP immunoreactivity in the young
SHR group.
We suggest that reduced glymphatic clearance of A and tau
could in part explain the link between AD and SVD. Future stud-
ies should aim to investigate whether similar changes in glym-
phatic activity exist in other models of hypertension and SVD,
and whether antihypertensive treatment helps correct glym-
phatic dysfunction. If atherosclerosis and stiffening of cerebral
vessels compromise brainwaste clearance, therapeutics formain-
taining vessel health and elasticity could be targets for minimiz-
ing A burden and impeding the progression of cognitive decline
in AD and VaD.
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